Bioscience Animal Health PCL

Bioscience Animal Health PCL Net Margin

The Net Profit Margin of Bioscience Animal Health PCL (BIS.BK) as of Oct 15, 2026 is 1.71 %. In the previous year, Net Profit Margin was 2.80 % — a change of -39.01% (lower).

Net Margin

1.71 %

YoY

-39.01%

Last updated:

Net Profit Margin of Bioscience Animal Health PCL is 2025 1.71 % . Net Profit Margin of Bioscience Animal Health PCL was 2024 2.80 % . It decreases by -39.01% lower compared to the previous year.

For Bioscience Animal Health PCL, the net margin of 1.7% is down versus 3.7% a few years ago.

The Bioscience Animal Health PCL Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
1.94 THB
Jan 1, 2019
9.84 THB
Jan 1, 2020
3.09 THB
Jan 1, 2021
3.67 THB
Jan 1, 2022
2.55 THB
Jan 1, 2023
2.10 THB
Jan 1, 2024
2.80 THB
Jan 1, 2025
1.71 THB
The Bioscience Animal Health PCL Net Margin history
YEARNet MarginYoY
1.71 %-39.01%
2.80 %+33.18%
2.10 %-17.51%
2.55 %-30.50%
3.67 %+18.54%
3.09 %-68.56%
9.84 %+407.95%
1.94 %-55.88%
4.39 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL, listed on the Stock Exchange of Thailand with ticker BIS.BK and ISIN THA776010003, operates in the Health Care sector. The company is headquartered in Pak Kret, Thailand, and completed its initial public offering on May 5, 2022. Bioscience Animal Health PCL is engaged in the manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company emphasizes collaboration with specialist veterinarians to select products aimed at enhancing animal health. Its product portfolio includes antibiotics, additives, BiSMiX B-Series, BiSMiX SD Series, injections, mold inhibitors, water-soluble products, and vaccines. Specific antibiotic products mentioned are Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Injection products include Zuprevo, Nuflor, Ceva, and Enzaprost. The company also provides services such as comprehensive farm advisory, disease prevention and surveillance programs, serological examination and diagnosis, biosafety and hygiene management, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring, and management and upskilling of farm personnel. The company's website is https://bis-group.com/. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioscience Animal Health PCL stock

Net Profit Margin of Bioscience Animal Health PCL is 1.71 % in 2025.

Net Profit Margin of Bioscience Animal Health PCL changed from 2.80 % to 1.71 %, representing a -39.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Bioscience Animal Health PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bioscience Animal Health PCL

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bioscience Animal Health PCL